Amgen gets US approval to treat immunoglobulin G4-related disease
HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.
Drugs
Health
Medical